Phenomenex, Designed

Phenomenex California

07.08.2025 - 18:06:58

Phenomenex broadens its Designed for PFAS Portfolio with the expansion of the Strata PFAS Solid Phase Extraction offerings for Enhanced PFAS Sample Preparation

portfolio offers a comprehensive range of formats that cater to various detection methods, including LC-MS/MS and combustion Ion Chromatography (CIC), empowering laboratories to tackle the complexities associated with PFAS analysis.  

"Phenomenex remains committed to staying at the forefront of PFAS sample preparation and analysis.  Knowing the PFAS workflow, we developed a "Designed for PFAS" portfolio and continued to expand its offerings with a Strata PFAS product line.  Coupled with our extensive technical support, it reflects our dedication to meeting the evolving needs of our customers," said Dr. Richard Jack, Global Market Development Manager at Phenomenex.

For more information, please visit https://www.phenomenex.com/pfas.

About Phenomenex 
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in academic, pharmaceutical, biotech, environmental, clinical research, government, and industrial laboratories.  From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve human health and well-being.  Phenomenex is an operating company within the Life Sciences group of Danaher Corporation.

For more information, please visit www.phenomenex.com and follow the company's blog at www.scienceunfiltered.com

Let's connect: LinkedIn, Instagram and YouTube

Photo - https://mma.prnewswire.com/media/2473880/Phenomenex_PFAS.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/phenomenex-broadens-its-designed-for-pfas-portfolio-with-the-expansion-of-the-strata-pfas-solid-phase-extraction-spe-offerings-for-enhanced-pfas-sample-preparation-302212619.html

@ prnewswire.co.uk